CME Group (CME) and the Depository Trust & Clearing Corporation, or DTCC, a post-trade market infrastructure for the global financial services industry, announced that their expanded cross-margining arrangement, designed to create additional capital efficiencies for market participants, has received regulatory approvals from the SEC and the Commodity Futures Trading Commission, or CFTC. Beginning April 30, DTCC and CME Group will extend the benefits of cross-margining to end-user clients of dually registered broker/dealers and futures commission merchants – FCMs – that are common members of both the DTCC’s Fixed Income Clearing Corporation, or FICC, and CME. Clients can benefit from increased capital and margin efficiencies when clearing transactions in U.S. Treasury securities through FICC and interest rate futures through CME when those transactions have offsetting risk exposures. CME-FICC cross-margining arrangements have been available to common clearing members with respect to their proprietary accounts since 2004, with significant enhancements to the arrangement announced in 2024. This latest expansion will now enable clearing members to extend equivalent margining benefits to their clients. CME Clearing allows participants to direct futures to end-user cross-margin accounts throughout the day, thereby making them available for offset in the cross-margin arrangement.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group price target raised to $329 from $313 at Piper Sandler
- CME Group to launch Eris SOFR Swap options on June 16
- CME Group price target lowered to $343 from $344 at Barclays
- Crypto Currents: Potential buyers reportedly looking at Gemini assets
- CME Group price target raised to $362 from $340 at Morgan Stanley
